Abbott Laboratories (ABT) shareholders
Close on Nov 17, 2026Market cap $181.19BP/E 33.7Yield 2.29%
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| BlackRock, Inc. | 134,061,311 | 7.70% | 13G (passive) amendment | Dec 31, 2023 |
| Vanguard Capital Management | 130,676,776 | 7.50% | 13G (passive) | Mar 31, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of ABT | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 152,563,476 | 8.82% | $13.84B | +6,876,018 | 0.21% |
| Vanguard Capital Management LLC | 113,750,994 | 6.57% | $10.32B | +801,061 | 0.22% |
| State Street Corp | 80,926,234 | 4.68% | $7.34B | +1,350,766 | 0.22% |
| Charles Schwab Investment Management Inc | 59,674,507 | 3.45% | $5.41B | +14,174,452 | 0.72% |
| Vanguard Portfolio Management LLC | 49,017,866 | 2.83% | $4.45B | +1,072,975 | 0.20% |
| Geode Capital Management, LLC | 39,219,337 | 2.27% | $3.54B | +70,542 | 0.19% |
| Capital Research Global Investors | 36,908,990 | 2.13% | $3.35B | −12,866,372 | 0.47% |
| Capital International Investors | 34,654,113 | 2.00% | $3.15B | −2,844,114 | 0.65% |
| Morgan Stanley | 26,611,315 | 1.54% | $2.41B | −3,490,281 | 0.13% |
| Norges Bank | 23,354,911 | 1.35% | $2.12B | New | 0.21% |
| Price T Rowe Associates Inc /Md/ | 22,787,202 | 1.32% | $2.07B | +5,509,990 | 0.21% |
| Franklin Resources Inc | 18,806,911 | 1.09% | $1.71B | −1,215,994 | 0.37% |
| Northern Trust Corp | 18,273,301 | 1.06% | $1.66B | −1,121,673 | 0.19% |
| Bank Of America Corp /De/ | 17,672,543 | 1.02% | $1.60B | −1,607,065 | 0.10% |
| Goldman Sachs Group Inc | 16,760,070 | 0.97% | $1.52B | +2,254,869 | 0.13% |
| Deutsche Bank AG\ | 16,706,669 | 0.97% | $1.52B | +2,614,965 | 0.44% |
| Wells Fargo & Company/Mn | 15,177,317 | 0.88% | $1.38B | −732,024 | 0.22% |
| JPMorgan Chase & Co | 15,095,898 | 0.87% | $1.40B | −11,671,201 | 0.08% |
| State Farm Mutual Automobile Insurance Co | 13,587,118 | 0.79% | $1.23B | – | 0.84% |
| FMR LLC | 13,423,080 | 0.78% | $1.22B | +2,577,765 | 0.05% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2,965 | 1.38B | 79.8% | 192 / 1059 | 1380 / 282 | 149M | 138M |
| Q1 2026 | 3,112 | 1.38B | 79.7% | 180 / 1116 | 1443 / 299 | 316M | 208M |
| Q4 2025 | 3,285 | 1.45B | 84.0% | 345 / 1149 | 1359 / 174 | 154M | 83M |
| Q3 2025 | 3,180 | 1.39B | 80.2% | 171 / 1200 | 1331 / 125 | 79M | 76M |
| Q2 2025 | 3,190 | 1.39B | 80.1% | 182 / 1328 | 1222 / 121 | 70M | 54M |
| Q1 2025 | 3,175 | 1.37B | 79.4% | 275 / 1137 | 1355 / 119 | 81M | 54M |
| Q4 2024 | 3,070 | 1.36B | 78.6% | 329 / 1127 | 1174 / 108 | 79M | 58M |
| Q3 2024 | 2,904 | 1.35B | 77.9% | 190 / 1082 | 1202 / 125 | 210M | 68M |
| Q2 2024 | 2,870 | 1.34B | 77.3% | 149 / 1145 | 1185 / 153 | 73M | 131M |
| Q1 2024 | 2,910 | 1.41B | 81.2% | 189 / 1165 | 1142 / 133 | 100M | 53M |
| Q4 2023 | 2,891 | 1.36B | 78.7% | 346 / 964 | 1220 / 96 | 108M | 44M |
| Q3 2023 | 2,684 | 1.30B | 75.2% | 146 / 980 | 1158 / 167 | 44M | 52M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
971 funds held ABT in Q2 2026, 52% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of ABT | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 55,297,279 | 3.20% | $5.02B | 0.22% | Jun 30, 2026 |
| Vanguard 500 Index Fund | 45,138,490 | 2.61% | $4.10B | 0.25% | Jun 30, 2026 |
| Schwab U.S. Dividend Equity ETF | 32,820,222 | 1.90% | $2.81B | 2.96% | May 31, 2026 |
| iShares Core S&P 500 ETF | 23,966,717 | 1.39% | $2.17B | 0.24% | Jun 30, 2026 |
| Fidelity 500 Index Fund | 22,252,385 | 1.29% | $1.90B | 0.23% | May 31, 2026 |
| Washington Mutual Investors Fund | 17,527,923 | 1.01% | $1.85B | 0.85% | Jul 31, 2026 |
| Vanguard Value Index Fund | 16,578,348 | 0.96% | $1.50B | 0.59% | Jun 30, 2026 |
| State Street(R) Health Care Select Sector SPDR(R) ETF | 12,305,409 | 0.71% | $1.12B | 2.75% | Jun 30, 2026 |
| Investment Co of America | 10,330,842 | 0.60% | $937.42M | 0.51% | Jun 30, 2026 |
| Vanguard Dividend Appreciation Index Fund | 9,855,078 | 0.57% | $1.04B | 0.80% | Jul 31, 2026 |
| Vanguard Institutional Index Fund | 9,455,763 | 0.55% | $858.02M | 0.24% | Jun 30, 2026 |
| American Mutual Fund | 8,092,368 | 0.47% | $855.36M | 0.73% | Jul 31, 2026 |
| Vanguard High Dividend Yield Index Fund | 6,977,447 | 0.40% | $737.52M | 0.74% | Jul 31, 2026 |
| Capital Income Builder | 6,768,329 | 0.39% | $715.41M | 0.55% | Jul 31, 2026 |
| MFS Value Fund | 6,618,090 | 0.38% | $566.51M | 1.11% | May 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Robert B. Ford | CHAIRMAN AND CEO, Director | 522,664 | 0.03% | Aug 27, 2026 |
| Mary K. Moreland | EXECUTIVE VICE PRESIDENT | 118,136 | 0.01% | Nov 6, 2026 |
| John A. McCoy Jr. | VICE PRESIDENT AND CONTROLLER | 24,608 | 0.00% | Sep 3, 2026 |
| Philip P. Boudreau | EVP AND CFO | 82,316 | 0.00% | Sep 3, 2026 |
| Louis H. Morrone | EXECUTIVE VICE PRESIDENT | 70,724 | 0.00% | Aug 13, 2026 |
| Elizabeth C. Cushman | EVP, GC AND SECRETARY | 38,013 | 0.00% | Jun 29, 2026 |
| Jacob A. Orville | Senior Vice President | 50,493 | 0.00% | Mar 25, 2026 |
| Daniel Gesua Sive Salvadori | EVP AND GROUP PRESIDENT | 146,377 | 0.01% | Mar 3, 2026 |
| Christopher J. Scoggins | EXECUTIVE VICE PRESIDENT | 77,126 | 0.00% | Mar 3, 2026 |
| Eric Shroff | Senior Vice President | 39,164 | 0.00% | Mar 3, 2026 |
| Lisa D. Earnhardt | EVP AND GROUP PRESIDENT | 90,407 | 0.01% | Mar 3, 2026 |
| Andrea F. Wainer | RETIRED EVP | 74,381 | 0.00% | Mar 4, 2025 |
| Hubert L. Allen | EXECUTIVE VICE PRESIDENT, GC | 191,899 | 0.01% | Mar 4, 2025 |
| Kevin T. Conroy | Director | 81,230 | 0.00% | Oct 2, 2026 |
| Nita Ahuja | Director | 2,286 | 0.00% | Oct 2, 2026 |
| Patricia Paola Gonzalez | Director | 9,205 | 0.00% | Oct 2, 2026 |
| John G. Stratton | Director | 23,319 | 0.00% | Oct 2, 2026 |
| Michael F. Roman | Director | 10,764 | 0.00% | Oct 2, 2026 |
| Sally E. Blount | Director | 36,344 | 0.00% | Apr 28, 2026 |
| Nancy McKinstry | Director | 41,010 | 0.00% | Apr 28, 2026 |
| Michael O'Grady | Director | 7,603 | 0.00% | Apr 28, 2026 |
| Michelle Kumbier | Director | 18,000 | 0.00% | Apr 28, 2026 |
| Daniel J. Starks | Director | 6,751,361 | 0.39% | Apr 28, 2026 |
| Darren W. McDew | Director | 12,678 | 0.00% | Apr 28, 2026 |
| Claire Babineaux-Fontenot | Director | 7,603 | 0.00% | Apr 28, 2026 |
| Robert J. Alpern | Director | 40,798 | 0.00% | Apr 2, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Mary K. Moreland EXECUTIVE VICE PRESIDENT | Nov 5, 2026 | Sale | −3,500 | $116.00 | $406.00K | 100,791 |
| Kevin T. Conroy Director | Sep 23, 2026 | Tax withholding | −52,507 | $103.99 | $5.46M | 81,230 |
| John A. McCoy Jr. VICE PRESIDENT AND CONTROLLER | Sep 2, 2026 | Sale | −27 | $109.54 | $2.96K | 24,549 |
| John A. McCoy Jr. VICE PRESIDENT AND CONTROLLER | Sep 1, 2026 | Tax withholding | −52 | $110.36 | $5.74K | 24,576 |
| Philip P. Boudreau EVP AND CFO | Sep 1, 2026 | Tax withholding | −388 | $110.36 | $42.82K | 70,784 |
| Robert B. Ford CHAIRMAN AND CEO, Director | Aug 25, 2026 | Sale | −180,297 | $116.19 | $20.95M | 306,461 |
| Robert B. Ford CHAIRMAN AND CEO, Director | Aug 25, 2026 | Sale | −218,535 | $115.57 | $25.26M | 486,758 |
| Robert B. Ford CHAIRMAN AND CEO, Director | Aug 25, 2026 | Option exercise | +246,963 | $59.94 | $14.80M | 705,293 |
| Robert B. Ford CHAIRMAN AND CEO, Director | Aug 25, 2026 | Option exercise | +151,869 | $44.40 | $6.74M | 458,330 |
| Louis H. Morrone EXECUTIVE VICE PRESIDENT | Aug 12, 2026 | Discretionary | −12 | $107.99 | $1.30K | 0 |
| Louis H. Morrone EXECUTIVE VICE PRESIDENT | Aug 11, 2026 | Sale | −5,850 | $109.83 | $642.51K | 70,724 |
| Louis H. Morrone EXECUTIVE VICE PRESIDENT | Jun 30, 2026 | Tax withholding | −269 | $92.71 | $24.94K | 76,574 |
| Elizabeth C. Cushman EVP, GC AND SECRETARY | Jun 27, 2026 | Tax withholding | −560 | $94.12 | $52.71K | 38,013 |
| John G. Stratton Director | May 7, 2026 | Buy | +2,000 | $86.82 | $173.64K | 23,319 |
| Mary K. Moreland EXECUTIVE VICE PRESIDENT | Apr 28, 2026 | Discretionary | +5,314 | $94.41 | $501.69K | 17,159 |
| Daniel J. Starks Director | Apr 27, 2026 | Buy | +10,000 | $92.65 | $926.50K | 6,751,103 |
| Kevin T. Conroy Director | Apr 24, 2026 | Award | +2,286 | – | – | 133,737 |
| Michael O'Grady Director | Apr 24, 2026 | Award | +2,286 | – | – | 7,603 |
| Michael F. Roman Director | Apr 24, 2026 | Award | +2,286 | – | – | 10,764 |
| Claire Babineaux-Fontenot Director | Apr 24, 2026 | Award | +2,286 | – | – | 7,603 |
| Daniel J. Starks Director | Apr 24, 2026 | Award | +2,286 | – | – | 6,741,103 |
| John G. Stratton Director | Apr 24, 2026 | Award | +2,286 | – | – | 21,319 |
| Michelle Kumbier Director | Apr 24, 2026 | Award | +2,286 | – | – | 18,000 |
| Nancy McKinstry Director | Apr 24, 2026 | Award | +2,286 | – | – | 41,010 |
| Sally E. Blount Director | Apr 24, 2026 | Award | +2,286 | – | – | 36,344 |
| Patricia Paola Gonzalez Director | Apr 24, 2026 | Award | +2,286 | – | – | 9,205 |
| Darren W. McDew Director | Apr 24, 2026 | Award | +2,286 | – | – | 12,678 |
| Nita Ahuja Director | Apr 24, 2026 | Award | +2,286 | – | – | 2,286 |
| Philip P. Boudreau EVP AND CFO | Apr 23, 2026 | Discretionary | +8,909 | $92.04 | $819.98K | 9,276 |
| Philip P. Boudreau EVP AND CFO | Apr 23, 2026 | Buy | +2,200 | $91.50 | $201.30K | 2,200 |
| Jacob A. Orville Senior Vice President | Mar 23, 2026 | Award | +13,255 | – | – | 50,493 |
| Eric Shroff Senior Vice President | Mar 2, 2026 | Sale | −709 | $115.58 | $81.95K | 39,164 |
| Daniel Gesua Sive Salvadori EVP AND GROUP PRESIDENT | Mar 2, 2026 | Sale | −885 | $115.58 | $102.29K | 146,377 |
| Elizabeth C. Cushman EVP, GC AND SECRETARY | Mar 2, 2026 | Sale | −263 | $115.58 | $30.40K | 38,573 |
| John A. McCoy Jr. VICE PRESIDENT AND CONTROLLER | Mar 2, 2026 | Sale | −585 | $115.58 | $67.61K | 24,628 |
| Mary K. Moreland EXECUTIVE VICE PRESIDENT | Mar 2, 2026 | Sale | −613 | $115.58 | $70.85K | 104,291 |
| Louis H. Morrone EXECUTIVE VICE PRESIDENT | Mar 2, 2026 | Sale | −1,144 | $115.58 | $132.22K | 76,843 |
| Eric Shroff Senior Vice President | Feb 27, 2026 | Tax withholding | −1,384 | $116.26 | $160.90K | 39,873 |
| Daniel Gesua Sive Salvadori EVP AND GROUP PRESIDENT | Feb 27, 2026 | Tax withholding | −6,615 | $116.26 | $769.06K | 147,262 |
| Robert B. Ford CHAIRMAN AND CEO, Director | Feb 27, 2026 | Tax withholding | −30,308 | $116.26 | $3.52M | 306,461 |
| Elizabeth C. Cushman EVP, GC AND SECRETARY | Feb 27, 2026 | Tax withholding | −1,421 | $116.26 | $165.21K | 38,836 |
| Lisa D. Earnhardt EVP AND GROUP PRESIDENT | Feb 27, 2026 | Tax withholding | −8,577 | $116.26 | $997.16K | 90,407 |
| John A. McCoy Jr. VICE PRESIDENT AND CONTROLLER | Feb 27, 2026 | Tax withholding | −1,142 | $116.26 | $132.77K | 25,213 |
| Mary K. Moreland EXECUTIVE VICE PRESIDENT | Feb 27, 2026 | Tax withholding | −4,630 | $116.26 | $538.28K | 104,904 |
| Philip P. Boudreau EVP AND CFO | Feb 27, 2026 | Tax withholding | −7,441 | $116.26 | $865.09K | 71,172 |
| Louis H. Morrone EXECUTIVE VICE PRESIDENT | Feb 27, 2026 | Tax withholding | −4,040 | $116.26 | $469.69K | 77,987 |
| Christopher J. Scoggins EXECUTIVE VICE PRESIDENT | Feb 27, 2026 | Tax withholding | −4,997 | $116.26 | $580.95K | 77,126 |
| Robert B. Ford CHAIRMAN AND CEO, Director | Feb 24, 2026 | Award | +83,464 | – | – | 336,769 |
| Louis H. Morrone EXECUTIVE VICE PRESIDENT | Feb 24, 2026 | Award | +15,418 | – | – | 82,027 |
| Lisa D. Earnhardt EVP AND GROUP PRESIDENT | Feb 24, 2026 | Award | +27,056 | – | – | 98,984 |
| Eric Shroff Senior Vice President | Feb 24, 2026 | Award | +10,873 | – | – | 41,257 |
| Daniel Gesua Sive Salvadori EVP AND GROUP PRESIDENT | Feb 24, 2026 | Award | +21,644 | – | – | 153,877 |
| Christopher J. Scoggins EXECUTIVE VICE PRESIDENT | Feb 24, 2026 | Award | +18,502 | – | – | 82,123 |
| Mary K. Moreland EXECUTIVE VICE PRESIDENT | Feb 24, 2026 | Award | +13,951 | – | – | 109,534 |
| John A. McCoy Jr. VICE PRESIDENT AND CONTROLLER | Feb 24, 2026 | Award | +5,373 | – | – | 26,355 |
| Elizabeth C. Cushman EVP, GC AND SECRETARY | Feb 24, 2026 | Award | +15,031 | – | – | 40,257 |
| Philip P. Boudreau EVP AND CFO | Feb 24, 2026 | Award | +27,997 | – | – | 78,613 |
| Daniel J. Starks Director | Feb 4, 2026 | Buy | +4,967 | $109.14 | $542.10K | 6,733,784 |
| Daniel J. Starks Director | Feb 4, 2026 | Buy | +5,033 | $108.33 | $545.22K | 6,738,817 |
| Robert B. Ford CHAIRMAN AND CEO, Director | Jan 23, 2026 | Buy | +18,800 | $107.13 | $2.01M | 216,203 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Abbott Laboratories's stock actually held short. Settlement fails (shares not delivered on time) peaked at 20,890 shares on Aug 24, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Mary K. Moreland Officer | Nov 5, 2026 | 3,500 | $406.00K | Nov 5, 2026 | Restricted Stock Award Vested |
| John A. McCoy Jr. Officer | Sep 2, 2026 | 27 | $2.96K | Sep 2, 2026 | Restricted Stock Award Vested |
| Robert B. Ford Officer, Director | Aug 25, 2026 | 398,832 | $46.20M | Aug 25, 2026 | Exercise of Stock Options |
| Louis H. Morrone Officer | Aug 11, 2026 | 5,850 | $642.51K | Aug 11, 2026 | Restricted Stock Award Vested |
| Robert J. Alpern Retired Director | May 15, 2026 | 7,587 | $646.79K | May 15, 2026 | RSUs Paid In Shares |
| Robert J. Alpern Retired Director | Apr 27, 2026 | 29,211 | $2.70M | Apr 27, 2026 | Restricted Stock Units |
| Elizabeth C. Cushman Officer | Mar 2, 2026 | 263 | $30.40K | Mar 2, 2026 | Restricted Stock Award Vested |
| John A. McCoy Jr. Officer | Mar 2, 2026 | 585 | $67.61K | Mar 2, 2026 | Restricted Stock Award Vested |
| Mary K. Moreland Officer | Mar 2, 2026 | 613 | $70.85K | Mar 2, 2026 | Restricted Stock Award Vested |
| Eric Shroff Officer | Mar 2, 2026 | 709 | $81.95K | Mar 2, 2026 | Restricted Stock Award Vested |
| Louis H. Morrone Officer | Mar 2, 2026 | 1,144 | $132.22K | Mar 2, 2026 | Restricted Stock Award Vested |
| Daniel Gesua Sive Salvadori Officer | Mar 2, 2026 | 885 | $102.29K | Mar 2, 2026 | Restricted Stock Award Vested |
| Eric Shroff Officer | Nov 25, 2025 | 1,586 | $203.04K | Nov 25, 2025 | Restricted Stock Award Vested |
| Philip P. Boudreau Officer | Aug 8, 2025 | 5,550 | $746.76K | Aug 8, 2025 | Restricted Stock Award Vested |
| Sally E. Blount Director | Apr 30, 2025 | 2,600 | $337.12K | Apr 30, 2025 | Open Market Purchase |
Congress trades
40 trades in Abbott Laboratories reported by 17 members of the House
| Member | Type | Traded | Amount | Filed |
|---|---|---|---|---|
| Pete Sessions TX17 · spouse | Sold | Oct 2, 2026 | $50K–100K | Oct 27, 2026 |
| Gilbert Cisneros CA31 | Bought | Sep 18, 2026 | $1K–15K | Oct 12, 2026 |
| Thomas H. Kean Jr NJ07 | Sold (part) | Sep 17, 2026 | $1K–15K | Oct 30, 2026 |
| Richard Dean Dr McCormick GA06 | Sold | Jul 30, 2026 | $1K–15K | Aug 14, 2026 |
| Mike Kelly PA16 · spouse | Sold | Jul 17, 2026 | $1K–15K | Aug 12, 2026 |
| Richard W. Allen GA12 · spouse | Sold | Jul 14, 2026 | $15K–50K | Aug 18, 2026 |
| Rick Larsen WA02 | Sold | Jul 8, 2026 | $1K–15K | Jul 12, 2026 |
| Gilbert Cisneros CA31 | Bought | Jun 16, 2026 | $1K–15K | Jul 2, 2026 |
| Richard Dean Dr McCormick GA06 | Bought | Jun 12, 2026 | $1K–15K | Jul 9, 2026 |
| Richard Dean Dr McCormick GA06 | Bought | Jun 12, 2026 | $1K–15K | Jul 9, 2026 |
| Josh Gottheimer NJ05 · joint account | Sold (part) | May 27, 2026 | $1K–15K | Jun 3, 2026 |
| Gilbert Cisneros CA31 | Sold | May 15, 2026 | $1K–15K | Jun 8, 2026 |
| Julie Johnson TX32 · joint account | Sold | May 12, 2026 | $1K–15K | Jun 12, 2026 |
| Richard W. Allen GA12 · spouse | Sold | Apr 16, 2026 | $15K–50K | Jun 5, 2026 50 days late |
| Laura Friedman CA30 | Exchanged | Mar 24, 2026 | $1K–15K | Apr 17, 2026 |
| Richard Dean Dr McCormick GA06 | Bought | Mar 19, 2026 | $1K–15K | Apr 7, 2026 |
| Gilbert Cisneros CA31 | Sold (part) | Feb 10, 2026 | $1K–15K | Mar 9, 2026 |
| Michael T. McCaul TX10 · spouse | Bought | Feb 5, 2026 | $15K–50K | Mar 10, 2026 |
| Thomas H. Kean Jr NJ07 | Bought | Jan 29, 2026 | $1K–15K | Feb 19, 2026 |
| Rohit Khanna CA17 · child | Bought | Dec 30, 2025 | $1K–15K | Jan 6, 2026 |
| Gilbert Cisneros CA31 | Sold (part) | Dec 19, 2025 | $1K–15K | Jan 12, 2026 |
| Julie Johnson TX32 · joint account | Sold | Dec 18, 2025 | $1K–15K | Jan 15, 2026 |
| Julia Letlow LA05 | Sold | Dec 8, 2025 | $1K–15K | Jan 13, 2026 |
| Byron Donalds FL19 · spouse | Sold | Dec 4, 2025 | $1K–15K | Jan 7, 2026 |
| Byron Donalds FL19 | Sold | Dec 4, 2025 | $1K–15K | Jan 7, 2026 |
| Gilbert Cisneros CA31 | Bought | Nov 18, 2025 | $1K–15K | Dec 15, 2025 |
| Julie Johnson TX32 · joint account | Sold (part) | Nov 13, 2025 | $1K–15K | Dec 11, 2025 |
| Richard Dean Dr McCormick GA06 | Bought | Nov 5, 2025 | $1K–15K | Dec 9, 2025 |
| Rick Larsen WA02 | Bought | Oct 6, 2025 | $1K–15K | Oct 16, 2025 |
| Julie Johnson TX32 · joint account | Sold (part) | Aug 14, 2025 | $1K–15K | Sep 11, 2025 |
| Rohit Khanna CA17 · child | Sold | Aug 6, 2025 | $1K–15K | Sep 9, 2025 |
| Thomas H. Kean Jr NJ07 | Bought | Jul 21, 2025 | $1K–15K | Aug 20, 2025 |
| Josh Gottheimer NJ05 · joint account | Sold (part) | Jul 18, 2025 | $1K–15K | Aug 11, 2025 |
| Lisa McClain MI09 · spouse | Sold | Jul 10, 2025 | $1K–15K | Aug 13, 2025 |
| Lisa McClain MI09 · spouse | Bought | Jun 24, 2025 | $1K–15K | Aug 13, 2025 50 days late |
| Jefferson Shreve IN06 | Sold | May 12, 2025 | $50K–100K | Jun 22, 2025 |
| Bruce Westerman AR04 | Sold | Apr 21, 2025 | $1K–15K | May 12, 2025 |
| Byron Donalds FL19 · spouse | Bought | Mar 20, 2025 | $1K–15K | Apr 14, 2025 |
| Byron Donalds FL19 | Bought | Mar 20, 2025 | $1K–15K | Apr 14, 2025 |
| Rohit Khanna CA17 · child | Bought | Mar 12, 2025 | $1K–15K | Apr 10, 2025 |
See a number that looks wrong?